Glycosolated enkephalin agents
OwnerRobin Polt, Edward Nilskyinventors
Life of this patent
Estimating the term…
Abstract
It is taught here that enkephalin peptides which are glycosylated with a disaccharide will be transported across the blood brain barrier and deliver analgesic effects superior to morphine when introduced into the bloodstream. Glycosylated peptides with disaccharides attached are superior to analogous peptides with either mono- or tri-saccharides attached.
Claims10
A method for delivering analgesia to an individual comprising administering to the bloodstream of the individual an effective amount of an analgesic molecule which is a glycosylated enkephalin, the glycosylation being a disaccharide sugar moiety.
A method for modifying a peptide enkephalin to enable the molecule to be transported across the blood-brain barrier, the method comprising the step of adding to the peptide a disaccharide moiety.
A compound of the formula X-O-G, wherein X is a peptide enkephalin which binds to an opioid receptor and G is a disaccharide sugar, the O-linkage of the peptide enkephalin to the disaccharide sugar being located on the peptide in the address region of the peptide.
A pharmaceutical composition comprising a drug delivery package labeled for use as a human drug, the package containing a glycosylated enkephalin peptide, the glycosylation being a disaccharide attached to the message region of the peptide.
The glycosylated peptide compound YtGFLS(b-melibiose)CONH2.
The glycosylated peptide compound YtGFLS(b-lactose)CONH2 in solution and packaged for use as an injectable pharmaceutical.
The glycosylated peptide compound YtGFLS(b-maltose)CONH2 in solution and packaged for use as an injectable pharmaceutical.
Dependencies are inferred from the claim text.